Nissim Benvenisty - Publications

Affiliations: 
The Azrieli Center for Stem Cells and Genetic Research Hebrew University, Jerusalem, Jerusalem, Israel 
Website:
http://benvenisty.huji.ac.il/people.html

155 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Lezmi E, Weissbein U, Golan-Lev T, Nissim-Rafinia M, Meshorer E, Benvenisty N. The Chromatin Regulator ZMYM2 Restricts Human Pluripotent Stem Cell Growth and Is Essential for Teratoma Formation. Stem Cell Reports. PMID 32559458 DOI: 10.1016/j.stemcr.2020.05.014  0.48
2019 Sagi I, De Pinho JC, Zuccaro MV, Atzmon C, Golan-Lev T, Yanuka O, Prosser R, Sadowy A, Perez G, Cabral T, Glaser B, Tsang SH, Goland R, Sauer MV, Lobo R, ... Benvenisty N, et al. Distinct Imprinting Signatures and Biased Differentiation of Human Androgenetic and Parthenogenetic Embryonic Stem Cells. Cell Stem Cell. 25: 419-432.e9. PMID 31491396 DOI: 10.1016/j.stem.2019.06.013  0.48
2019 Vershkov D, Fainstein N, Suissa S, Golan-Lev T, Ben-Hur T, Benvenisty N. FMR1 Reactivating Treatments in Fragile X iPSC-Derived Neural Progenitors In Vitro and In Vivo. Cell Reports. 26: 2531-2539.e4. PMID 30840878 DOI: 10.1016/j.celrep.2019.02.026  0.48
2019 Weissbein U, Peretz M, Plotnik O, Yanuka O, Sagi I, Golan-Lev T, Benvenisty N. Genome-wide Screen for Culture Adaptation and Tumorigenicity-Related Genes in Human Pluripotent Stem Cells. Iscience. 11: 398-408. PMID 30660107 DOI: 10.1016/j.isci.2018.12.031  0.48
2017 Hecht M, Tabib A, Kahan T, Orlanski S, Gropp M, Tabach Y, Yanuka O, Benvenisty N, Keshet I, Cedar H. Epigenetic mechanism of FMR1 inactivation in Fragile X syndrome. The International Journal of Developmental Biology. 61: 285-292. PMID 28621425 DOI: 10.1387/ijdb.170022hc  0.4
2016 Halevy T, Biancotti JC, Yanuka O, Golan-Lev T, Benvenisty N. Molecular Characterization of Down Syndrome Embryonic Stem Cells Reveals a Role for RUNX1 in Neural Differentiation. Stem Cell Reports. PMID 27618722 DOI: 10.1016/j.stemcr.2016.08.003  0.48
2016 Halevy T, Akov S, Bohndorf M, Mlody B, Adjaye J, Benvenisty N, Goldberg M. Chromosomal Instability and Molecular Defects in Induced Pluripotent Stem Cells from Nijmegen Breakage Syndrome Patients. Cell Reports. PMID 27545893 DOI: 10.1016/j.celrep.2016.07.071  1
2016 Daley GQ, Hyun I, Apperley JF, Barker RA, Benvenisty N, Bredenoord AL, Breuer CK, Caulfield T, Cedars MI, Frey-Vasconcells J, Heslop HE, Jin Y, Lee RT, McCabe C, Munsie M, et al. Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines. Stem Cell Reports. PMID 27185282 DOI: 10.1016/j.stemcr.2016.05.001  1
2016 Sagi I, Chia G, Golan-Lev T, Peretz M, Weissbein U, Sui L, Sauer MV, Yanuka O, Egli D, Benvenisty N. Derivation and differentiation of haploid human embryonic stem cells. Nature. PMID 26982723 DOI: 10.1038/nature17408  1
2016 Avior Y, Sagi I, Benvenisty N. Pluripotent stem cells in disease modelling and drug discovery. Nature Reviews. Molecular Cell Biology. PMID 26818440 DOI: 10.1038/nrm.2015.27  1
2015 Lamm N, Ben-David U, Golan-Lev T, Storchová Z, Benvenisty N, Kerem B. Genomic Instability in Human Pluripotent Stem Cells Arises from Replicative Stress and Chromosome Condensation Defects. Cell Stem Cell. PMID 26669899 DOI: 10.1016/j.stem.2015.11.003  1
2015 Brennand KJ, Marchetto MC, Benvenisty N, Brüstle O, Ebert A, Izpisua Belmonte JC, Kaykas A, Lancaster MA, Livesey FJ, McConnell MJ, McKay RD, Morrow EM, Muotri AR, Panchision DM, Rubin LL, et al. Creating Patient-Specific Neural Cells for the In Vitro Study of Brain Disorders. Stem Cell Reports. PMID 26610635 DOI: 10.1016/j.stemcr.2015.10.011  1
2015 Park CY, Halevy T, Lee DR, Sung JJ, Lee JS, Yanuka O, Benvenisty N, Kim DW. Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons. Cell Reports. PMID 26440889 DOI: 10.1016/j.celrep.2015.08.084  1
2015 De Los Angeles A, Ferrari F, Xi R, Fujiwara Y, Benvenisty N, Deng H, Hochedlinger K, Jaenisch R, Lee S, Leitch HG, Lensch MW, Lujan E, Pei D, Rossant J, Wernig M, et al. Hallmarks of pluripotency. Nature. 525: 469-78. PMID 26399828 DOI: 10.1038/nature15515  1
2015 Weissbein U, Benvenisty N. rsPSCs: A new type of pluripotent stem cells. Cell Research. PMID 26077383 DOI: 10.1038/cr.2015.73  1
2015 Avior Y, Biancotti JC, Benvenisty N. TeratoScore: Assessing the Differentiation Potential of Human Pluripotent Stem Cells by Quantitative Expression Analysis of Teratomas. Stem Cell Reports. 4: 967-74. PMID 26070610 DOI: 10.1016/j.stemcr.2015.05.006  1
2015 Stelzer Y, Bar S, Bartok O, Afik S, Ronen D, Kadener S, Benvenisty N. Differentiation of human parthenogenetic pluripotent stem cells reveals multiple tissue- and isoform-specific imprinted transcripts. Cell Reports. 11: 308-20. PMID 25843718 DOI: 10.1016/j.celrep.2015.03.023  1
2015 Halevy T, Czech C, Benvenisty N. Molecular mechanisms regulating the defects in fragile X syndrome neurons derived from human pluripotent stem cells. Stem Cell Reports. 4: 37-46. PMID 25483109 DOI: 10.1016/j.stemcr.2014.10.015  1
2015 Ben-David U, Cowell IG, Austin CA, Benvenisty N. Brief reports: Controlling the survival of human pluripotent stem cells by small molecule-based targeting of topoisomerase II alpha. Stem Cells (Dayton, Ohio). 33: 1013-9. PMID 25377277 DOI: 10.1002/stem.1888  1
2014 Johannesson B, Sagi I, Gore A, Paull D, Yamada M, Golan-Lev T, Li Z, LeDuc C, Shen Y, Stern S, Xu N, Ma H, Kang E, Mitalipov S, Sauer MV, ... ... Benvenisty N, et al. Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors. Cell Stem Cell. 15: 634-42. PMID 25517467 DOI: 10.1016/j.stem.2014.10.002  1
2014 Weissbein U, Ben-David U, Benvenisty N. Virtual karyotyping reveals greater chromosomal stability in neural cells derived by transdifferentiation than those from stem cells. Cell Stem Cell. 15: 687-91. PMID 25479746 DOI: 10.1016/j.stem.2014.10.018  1
2014 Ben-David U, Arad G, Weissbein U, Mandefro B, Maimon A, Golan-Lev T, Narwani K, Clark AT, Andrews PW, Benvenisty N, Carlos Biancotti J. Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells. Nature Communications. 5: 4825. PMID 25198699 DOI: 10.1038/ncomms5825  1
2014 Ronen D, Benvenisty N. Sex-dependent gene expression in human pluripotent stem cells. Cell Reports. 8: 923-32. PMID 25127145 DOI: 10.1016/j.celrep.2014.07.013  1
2014 Ludwig G, Nejman D, Hecht M, Orlanski S, Abu-Remaileh M, Yanuka O, Sandler O, Marx A, Roberts D, Benvenisty N, Bergman Y, Mendelsohn M, Cedar H. Aberrant DNA methylation in ES cells. Plos One. 9: e96090. PMID 24852222 DOI: 10.1371/journal.pone.0096090  1
2014 Stelzer Y, Sagi I, Yanuka O, Eiges R, Benvenisty N. The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome. Nature Genetics. 46: 551-7. PMID 24816254 DOI: 10.1038/ng.2968  1
2014 Yamada M, Johannesson B, Sagi I, Burnett LC, Kort DH, Prosser RW, Paull D, Nestor MW, Freeby M, Greenberg E, Goland RS, Leibel RL, Solomon SL, Benvenisty N, Sauer MV, et al. Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells. Nature. 510: 533-6. PMID 24776804 DOI: 10.1038/nature13287  1
2014 Ben-David U, Biran A, Scaffidi P, Herold-Mende C, Boehringer M, Meshorer E, Benvenisty N. Elimination of undifferentiated cancer cells by pluripotent stem cell inhibitors. Journal of Molecular Cell Biology. 6: 267-9. PMID 24683201 DOI: 10.1093/jmcb/mju012  1
2014 Ben-David U, Benvenisty N. Chemical ablation of tumor-initiating human pluripotent stem cells. Nature Protocols. 9: 729-40. PMID 24577362 DOI: 10.1038/nprot.2014.050  1
2014 Weissbein U, Benvenisty N, Ben-David U. Quality control: Genome maintenance in pluripotent stem cells. The Journal of Cell Biology. 204: 153-63. PMID 24446481 DOI: 10.1083/jcb.201310135  1
2013 Nissenbaum J, Bar-Nur O, Ben-David E, Benvenisty N. Global indiscriminate methylation in cell-specific gene promoters following reprogramming into human induced pluripotent stem cells. Stem Cell Reports. 1: 509-17. PMID 24371806 DOI: 10.1016/j.stemcr.2013.11.007  1
2013 Stelzer Y, Sagi I, Benvenisty N. Involvement of parental imprinting in the antisense regulation of onco-miR-372-373. Nature Communications. 4: 2724. PMID 24201333 DOI: 10.1038/ncomms3724  1
2013 Stelzer Y, Ronen D, Bock C, Boyle P, Meissner A, Benvenisty N. Identification of novel imprinted differentially methylated regions by global analysis of human-parthenogenetic-induced pluripotent stem cells. Stem Cell Reports. 1: 79-89. PMID 24052944 DOI: 10.1016/j.stemcr.2013.03.005  1
2013 Bruck T, Yanuka O, Benvenisty N. Human pluripotent stem cells with distinct X inactivation status show molecular and cellular differences controlled by the X-Linked ELK-1 gene. Cell Reports. 4: 262-70. PMID 23871667 DOI: 10.1016/j.celrep.2013.06.026  1
2013 Ben-David U, Nudel N, Benvenisty N. Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells. Nature Communications. 4: 1992. PMID 23778593 DOI: 10.1038/ncomms2992  1
2013 Ben-David U, Nissenbaum J, Benvenisty N. New balance in pluripotency: reprogramming with lineage specifiers. Cell. 153: 939-40. PMID 23706730 DOI: 10.1016/j.cell.2013.04.051  1
2013 Ben-David U, Mayshar Y, Benvenisty N. Virtual karyotyping of pluripotent stem cells on the basis of their global gene expression profiles. Nature Protocols. 8: 989-97. PMID 23619890 DOI: 10.1038/nprot.2013.051  1
2013 Ben-David U, Gan QF, Golan-Lev T, Arora P, Yanuka O, Oren YS, Leikin-Frenkel A, Graf M, Garippa R, Boehringer M, Gromo G, Benvenisty N. Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. Cell Stem Cell. 12: 167-79. PMID 23318055 DOI: 10.1016/j.stem.2012.11.015  1
2013 Mayshar Y, Benvenisty N. Genetic Manipulation of Human Embryonic Stem Cells Handbook of Stem Cells. 1: 327-337. DOI: 10.1016/B978-0-12-385942-6.00026-3  1
2012 Ronen D, Benvenisty N. Genomic stability in reprogramming. Current Opinion in Genetics & Development. 22: 444-9. PMID 23040504 DOI: 10.1016/j.gde.2012.09.003  1
2012 Sharon N, Mor I, Zahavi E, Benvenisty N. DUXO, a novel double homeobox transcription factor, is a regulator of the gastrula organizer in human embryonic stem cells. Stem Cell Research. 9: 261-9. PMID 23010573 DOI: 10.1016/j.scr.2012.08.003  1
2012 Pick M, Ronen D, Yanuka O, Benvenisty N. Reprogramming of the MHC-I and its regulation by NFκB in human-induced pluripotent stem cells. Stem Cells (Dayton, Ohio). 30: 2700-8. PMID 22987393 DOI: 10.1002/stem.1242  1
2012 Biancotti JC, Narwani K, Mandefro B, Golan-Lev T, Buehler N, Hill D, Svendsen CN, Benvenisty N. The in vitro survival of human monosomies and trisomies as embryonic stem cells. Stem Cell Research. 9: 218-24. PMID 22892439 DOI: 10.1016/j.scr.2012.07.002  1
2012 Ben-David U, Kopper O, Benvenisty N. Expanding the boundaries of embryonic stem cells. Cell Stem Cell. 10: 666-77. PMID 22704506 DOI: 10.1016/j.stem.2012.05.003  1
2012 Fishman B, Segev H, Kopper O, Nissenbaum J, Schulman M, Benvenisty N, Itskovitz-Eldor J, Kitsberg D. Targeting pancreatic progenitor cells in human embryonic stem cell differentiation for the identification of novel cell surface markers. Stem Cell Reviews. 8: 792-802. PMID 22592939 DOI: 10.1007/s12015-012-9363-x  1
2012 Bar-Nur O, Caspi I, Benvenisty N. Molecular analysis of FMR1 reactivation in fragile-X induced pluripotent stem cells and their neuronal derivatives. Journal of Molecular Cell Biology. 4: 180-3. PMID 22430918 DOI: 10.1093/jmcb/mjs007  1
2012 Ben-David U, Benvenisty N. High prevalence of evolutionarily conserved and species-specific genomic aberrations in mouse pluripotent stem cells. Stem Cells (Dayton, Ohio). 30: 612-22. PMID 22328490 DOI: 10.1002/stem.1057  1
2012 Kopper O, Benvenisty N. Stepwise differentiation of human embryonic stem cells into early endoderm derivatives and their molecular characterization. Stem Cell Research. 8: 335-45. PMID 22286009 DOI: 10.1016/j.scr.2011.12.006  1
2012 Bar-Nur O, Russ HA, Efrat S, Benvenisty N. Erattum: Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells (Cell Stem Cell (2011) 9 (17-23)) Cell Stem Cell. 11: 854. DOI: 10.1016/j.stem.2012.11.007  1
2012 Ben-David U, Mayshar Y, Benvenisty N. Significant acquisition of chromosomal aberrations in human adult mesenchymal stem cells: Response to Sensebé et al Cell Stem Cell. 10: 10-11. DOI: 10.1016/j.stem.2011.12.007  1
2011 Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB, Beil S, Benvenisty N, Ben-Yosef D, Biancotti JC, Bosman A, et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nature Biotechnology. 29: 1132-44. PMID 22119741 DOI: 10.1038/nbt.2051  1
2011 Ben-David U, Mayshar Y, Benvenisty N. Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell. 9: 97-102. PMID 21816361 DOI: 10.1016/j.stem.2011.06.013  1
2011 Biancotti JC, Benvenisty N. Aneuploid human embryonic stem cells: origins and potential for modeling chromosomal disorders. Regenerative Medicine. 6: 493-503. PMID 21749207 DOI: 10.2217/rme.11.27  1
2011 Bar-Nur O, Russ HA, Efrat S, Benvenisty N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell. 9: 17-23. PMID 21726830 DOI: 10.1016/j.stem.2011.06.007  1
2011 Goldring CE, Duffy PA, Benvenisty N, Andrews PW, Ben-David U, Eakins R, French N, Hanley NA, Kelly L, Kitteringham NR, Kurth J, Ladenheim D, Laverty H, McBlane J, Narayanan G, et al. Assessing the safety of stem cell therapeutics. Cell Stem Cell. 8: 618-28. PMID 21624806 DOI: 10.1016/j.stem.2011.05.012  1
2011 Stelzer Y, Yanuka O, Benvenisty N. Global analysis of parental imprinting in human parthenogenetic induced pluripotent stem cells. Nature Structural & Molecular Biology. 18: 735-41. PMID 21572443 DOI: 10.1038/nsmb.2050  1
2011 Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nature Reviews. Cancer. 11: 268-77. PMID 21390058 DOI: 10.1038/nrc3034  1
2011 Sharon N, Mor I, Golan-lev T, Fainsod A, Benvenisty N. Molecular and functional characterizations of gastrula organizer cells derived from human embryonic stem cells. Stem Cells (Dayton, Ohio). 29: 600-8. PMID 21328508 DOI: 10.1002/stem.621  1
2011 Knoppers BM, Isasi R, Benvenisty N, Kim OJ, Lomax G, Morris C, Murray TH, Lee EH, Perry M, Richardson G, Sipp D, Tanner K, Wahlström J, de Wert G, Zeng F. Publishing SNP genotypes of human embryonic stem cell lines: policy statement of the International Stem Cell Forum Ethics Working Party. Stem Cell Reviews. 7: 482-4. PMID 21279481 DOI: 10.1007/s12015-010-9226-2  1
2011 Bruck T, Benvenisty N. Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells. Stem Cell Research. 6: 187-93. PMID 21276761 DOI: 10.1016/j.scr.2010.12.001  1
2011 Mayshar Y, Yanuka O, Benvenisty N. Teratogen screening using transcriptome profiling of differentiating human embryonic stem cells. Journal of Cellular and Molecular Medicine. 15: 1393-401. PMID 20561110 DOI: 10.1111/j.1582-4934.2010.01105.x  1
2010 Ben-David U, Benvenisty N, Mayshar Y. Genetic instability in human induced pluripotent stem cells: classification of causes and possible safeguards. Cell Cycle (Georgetown, Tex.). 9: 4603-4. PMID 21099357 DOI: 10.4161/cc.9.23.14094  1
2010 Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT, Plath K, Lowry WE, Benvenisty N. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell. 7: 521-31. PMID 20887957 DOI: 10.1016/j.stem.2010.07.017  1
2010 Ellis J, Baum C, Benvenisty N, Mostoslavsky G, Okano H, Stanford WL, Porteus M, Sadelain M. Benefits of utilizing gene-modified iPSCs for clinical applications. Cell Stem Cell. 7: 429-30. PMID 20887948 DOI: 10.1016/j.stem.2010.09.010  1
2010 Biancotti JC, Narwani K, Buehler N, Mandefro B, Golan-Lev T, Yanuka O, Clark A, Hill D, Benvenisty N, Lavon N. Human embryonic stem cells as models for aneuploid chromosomal syndromes. Stem Cells (Dayton, Ohio). 28: 1530-40. PMID 20641042 DOI: 10.1002/stem.483  1
2010 Urbach A, Bar-Nur O, Daley GQ, Benvenisty N. Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell. 6: 407-11. PMID 20452313 DOI: 10.1016/j.stem.2010.04.005  1
2010 Närvä E, Autio R, Rahkonen N, Kong L, Harrison N, Kitsberg D, Borghese L, Itskovitz-Eldor J, Rasool O, Dvorak P, Hovatta O, Otonkoski T, Tuuri T, Cui W, Brüstle O, ... ... Benvenisty N, et al. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nature Biotechnology. 28: 371-7. PMID 20351689 DOI: 10.1038/nbt.1615  1
2010 Narwani K, Biancotti JC, Golan-Lev T, Buehler N, Hill D, Shifman S, Benvenisty N, Lavon N. Human embryonic stem cells from aneuploid blastocysts identified by pre-implantation genetic screening. In Vitro Cellular & Developmental Biology. Animal. 46: 309-16. PMID 20224970 DOI: 10.1007/s11626-010-9303-5  1
2010 Andrews PW, Benvenisty N, Knowles BB, McKay RD, Oh SK, Pera MF, Rossant J, Stacey GN. Human ES cell lines--introduction. In Vitro Cellular & Developmental Biology. Animal. 46: 167-8. PMID 20213278 DOI: 10.1007/s11626-010-9306-2  1
2010 Akopian V, Andrews PW, Beil S, Benvenisty N, Brehm J, Christie M, Ford A, Fox V, Gokhale PJ, Healy L, Holm F, Hovatta O, Knowles BB, Ludwig TE, et al. Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. In Vitro Cellular & Developmental Biology. Animal. 46: 247-58. PMID 20186512 DOI: 10.1007/s11626-010-9297-z  1
2010 Kopper O, Giladi O, Golan-Lev T, Benvenisty N. Characterization of gastrulation-stage progenitor cells and their inhibitory crosstalk in human embryoid bodies. Stem Cells (Dayton, Ohio). 28: 75-83. PMID 19921748 DOI: 10.1002/stem.260  1
2009 Brevini TA, Pennarossa G, Antonini S, Paffoni A, Tettamanti G, Montemurro T, Radaelli E, Lazzari L, Rebulla P, Scanziani E, de Eguileor M, Benvenisty N, Ragni G, Gandolfi F. Cell lines derived from human parthenogenetic embryos can display aberrant centriole distribution and altered expression levels of mitotic spindle check-point transcripts. Stem Cell Reviews. 5: 340-52. PMID 20058199 DOI: 10.1007/s12015-009-9086-9  1
2009 Blum B, Benvenisty N. The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle (Georgetown, Tex.). 8: 3822-30. PMID 19887907  1
2009 Pick M, Stelzer Y, Bar-Nur O, Mayshar Y, Eden A, Benvenisty N. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells (Dayton, Ohio). 27: 2686-90. PMID 19711451 DOI: 10.1002/stem.205  1
2009 Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Richter L, Zhang J, Khvorostov I, Ott V, Grunstein M, Lavon N, Benvenisty N, et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell. 5: 111-23. PMID 19570518 DOI: 10.1016/j.stem.2009.06.008  1
2009 Straussman R, Nejman D, Roberts D, Steinfeld I, Blum B, Benvenisty N, Simon I, Yakhini Z, Cedar H. Developmental programming of CpG island methylation profiles in the human genome. Nature Structural & Molecular Biology. 16: 564-71. PMID 19377480 DOI: 10.1038/nsmb.1594  1
2009 Blum B, Bar-Nur O, Golan-Lev T, Benvenisty N. The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nature Biotechnology. 27: 281-7. PMID 19252483 DOI: 10.1038/nbt.1527  1
2009 Urbach A, Benvenisty N. Studying early lethality of 45,XO (Turner's syndrome) embryos using human embryonic stem cells. Plos One. 4: e4175. PMID 19137066 DOI: 10.1371/journal.pone.0004175  1
2009 Darr H, Benvenisty N. Genetic analysis of the role of the reprogramming gene LIN-28 in human embryonic stem cells. Stem Cells (Dayton, Ohio). 27: 352-62. PMID 19038789 DOI: 10.1634/stemcells.2008-0720  1
2008 Blum B, Benvenisty N. The tumorigenicity of human embryonic stem cells. Advances in Cancer Research. 100: 133-58. PMID 18620095 DOI: 10.1016/S0065-230X(08)00005-5  1
2008 Lavon N, Narwani K, Golan-Lev T, Buehler N, Hill D, Benvenisty N. Derivation of euploid human embryonic stem cells from aneuploid embryos. Stem Cells (Dayton, Ohio). 26: 1874-82. PMID 18450823 DOI: 10.1634/stemcells.2008-0156  1
2008 Mayshar Y, Rom E, Chumakov I, Kronman A, Yayon A, Benvenisty N. Fibroblast growth factor 4 and its novel splice isoform have opposing effects on the maintenance of human embryonic stem cell self-renewal. Stem Cells (Dayton, Ohio). 26: 767-74. PMID 18192227 DOI: 10.1634/stemcells.2007-1037  1
2007 Eiges R, Urbach A, Malcov M, Frumkin T, Schwartz T, Amit A, Yaron Y, Eden A, Yanuka O, Benvenisty N, Ben-Yosef D. Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell. 1: 568-77. PMID 18371394 DOI: 10.1016/j.stem.2007.09.001  1
2007 Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW, Beighton G, Bello PA, Benvenisty N, Berry LS, Bevan S, Blum B, Brooking J, Chen KG, Choo AB, et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nature Biotechnology. 25: 803-16. PMID 17572666 DOI: 10.1038/nbt1318  1
2007 Blum B, Benvenisty N. Clonal analysis of human embryonic stem cell differentiation into teratomas. Stem Cells (Dayton, Ohio). 25: 1924-30. PMID 17464084 DOI: 10.1634/stemcells.2007-0073  1
2007 Daley GQ, Ahrlund Richter L, Auerbach JM, Benvenisty N, Charo RA, Chen G, Deng HK, Goldstein LS, Hudson KL, Hyun I, Junn SC, Love J, Lee EH, McLaren A, Mummery CL, et al. Ethics. The ISSCR guidelines for human embryonic stem cell research. Science (New York, N.Y.). 315: 603-4. PMID 17272706 DOI: 10.1126/science.1139337  1
2007 Dvash T, Sharon N, Yanuka O, Benvenisty N. Molecular analysis of LEFTY-expressing cells in early human embryoid bodies. Stem Cells (Dayton, Ohio). 25: 465-72. PMID 17038673 DOI: 10.1634/stemcells.2006-0179  1
2007 Lavon N, Benvenisty N. Part B: Directed Differentiation of Human Embryonic Stem Cells into Hepatic Cells Human Embryonic Stem Cells: the Practical Handbook. 187-194. DOI: 10.1002/9780470511619.ch12b  1
2006 Darr H, Benvenisty N. Human embryonic stem cells: the battle between self-renewal and differentiation. Regenerative Medicine. 1: 317-25. PMID 17465785 DOI: 10.2217/17460751.1.3.317  1
2006 Friedrich Ben-Nun I, Benvenisty N. Human embryonic stem cells as a cellular model for human disorders. Molecular and Cellular Endocrinology. 252: 154-9. PMID 16690205 DOI: 10.1016/j.mce.2006.03.034  1
2006 Lavon N, Yanuka O, Benvenisty N. The effect of overexpression of Pdx1 and Foxa2 on the differentiation of human embryonic stem cells into pancreatic cells. Stem Cells (Dayton, Ohio). 24: 1923-30. PMID 16675598 DOI: 10.1634/stemcells.2005-0397  1
2006 Darr H, Mayshar Y, Benvenisty N. Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development (Cambridge, England). 133: 1193-201. PMID 16501172 DOI: 10.1242/dev.02286  1
2006 Darr H, Benvenisty N. Factors involved in self-renewal and pluripotency of embryonic stem cells. Handbook of Experimental Pharmacology. 1-19. PMID 16370322 DOI: 10.1007/3-540-31265-X-1  1
2006 Drukker M, Katchman H, Katz G, Even-Tov Friedman S, Shezen E, Hornstein E, Mandelboim O, Reisner Y, Benvenisty N. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells (Dayton, Ohio). 24: 221-9. PMID 16109762 DOI: 10.1634/stemcells.2005-0188  1
2005 Kopper O, Benvenisty N. Manipulation of the human genome in human embryonic stem cells. Stem Cell Reviews. 1: 145-50. PMID 17142849 DOI: 10.1385/SCR:1:2:145  1
2005 Lavon N, Benvenisty N. Study of hepatocyte differentiation using embryonic stem cells. Journal of Cellular Biochemistry. 96: 1193-202. PMID 16211581 DOI: 10.1002/jcb.20590  1
2005 Andrews PW, Benvenisty N, McKay R, Pera MF, Rossant J, Semb H, Stacey GN. The International Stem Cell Initiative: toward benchmarks for human embryonic stem cell research. Nature Biotechnology. 23: 795-7. PMID 16003358 DOI: 10.1038/nbt0705-795  1
2005 Andrews PW, Benvenisty N. Starting from building blocks: Tissue engineering using stem cells Current Opinion in Biotechnology. 16: 485-486. DOI: 10.1016/j.copbio.2005.09.002  1
2004 Dvash T, Benvenisty N. Human embryonic stem cells as a model for early human development. Best Practice & Research. Clinical Obstetrics & Gynaecology. 18: 929-40. PMID 15582547 DOI: 10.1016/j.bpobgyn.2004.06.005  1
2004 Dvash T, Mayshar Y, Darr H, McElhaney M, Barker D, Yanuka O, Kotkow KJ, Rubin LL, Benvenisty N, Eiges R. Temporal gene expression during differentiation of human embryonic stem cells and embryoid bodies. Human Reproduction (Oxford, England). 19: 2875-83. PMID 15375076 DOI: 10.1093/humrep/deh529  1
2004 Dhara SK, Benvenisty N. Gene trap as a tool for genome annotation and analysis of X chromosome inactivation in human embryonic stem cells. Nucleic Acids Research. 32: 3995-4002. PMID 15284332 DOI: 10.1093/nar/gkh746  1
2004 Urbach A, Schuldiner M, Benvenisty N. Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. Stem Cells (Dayton, Ohio). 22: 635-41. PMID 15277709 DOI: 10.1634/stemcells.22-4-635  1
2004 Lavon N, Yanuka O, Benvenisty N. Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation; Research in Biological Diversity. 72: 230-8. PMID 15270779 DOI: 10.1111/j.1432-0436.2004.07205002.x  1
2004 Hornstein E, Benvenisty N. The "brainy side" of human embryonic stem cells. Journal of Neuroscience Research. 76: 169-73. PMID 15048914 DOI: 10.1002/jnr.20034  1
2004 Drukker M, Benvenisty N. The immunogenicity of human embryonic stem-derived cells. Trends in Biotechnology. 22: 136-41. PMID 15036864 DOI: 10.1016/j.tibtech.2004.01.003  1
2004 Drukker M, Katz G, Mandelboim O, Benvenisty N. Immunogenicity of Human Embryonic Stem Cells Handbook of Stem Cells. 1: 663-674. DOI: 10.1016/B978-012436643-5/50075-4  1
2003 Schuldiner M, Benvenisty N. Factors controlling human embryonic stem cell differentiation. Methods in Enzymology. 365: 446-61. PMID 14696364 DOI: 10.1016/S0076-6879(03)65031-7  1
2003 Schuldiner M, Itskovitz-Eldor J, Benvenisty N. Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells (Dayton, Ohio). 21: 257-65. PMID 12743320 DOI: 10.1634/stemcells.21-3-257  1
2003 Lavon N, Benvenisty N. Differentiation and genetic manipulation of human embryonic stem cells and the analysis of the cardiovascular system. Trends in Cardiovascular Medicine. 13: 47-52. PMID 12586438 DOI: 10.1016/S1050-1738(02)00199-8  1
2002 Eiges R, Benvenisty N. A molecular view on pluripotent stem cells. Febs Letters. 529: 135-41. PMID 12354626 DOI: 10.1016/S0014-5793(02)03191-5  1
2002 Goldstein RS, Drukker M, Reubinoff BE, Benvenisty N. Integration and differentiation of human embryonic stem cells transplanted to the chick embryo. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 225: 80-6. PMID 12203723 DOI: 10.1002/dvdy.10108  1
2002 Schuldiner O, Shor S, Benvenisty N. A computerized database-scan to identify c-MYC targets. Gene. 292: 91-9. PMID 12119103 DOI: 10.1016/S0378-1119(02)00668-6  1
2002 Drukker M, Katz G, Urbach A, Schuldiner M, Markel G, Itskovitz-Eldor J, Reubinoff B, Mandelboim O, Benvenisty N. Characterization of the expression of MHC proteins in human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 99: 9864-9. PMID 12114532 DOI: 10.1073/pnas.142298299  1
2002 Benvenisty N. Europe and the stem cell debate. Trends in Biotechnology. 20: 183. PMID 11943365 DOI: 10.1016/S0167-7799(02)01941-8  1
2001 Schuldiner M, Eiges R, Eden A, Yanuka O, Itskovitz-Eldor J, Goldstein RS, Benvenisty N. Induced neuronal differentiation of human embryonic stem cells. Brain Research. 913: 201-5. PMID 11549388 DOI: 10.1016/S0006-8993(01)02776-7  1
2001 Schuldiner O, Benvenisty N. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors. Oncogene. 20: 4984-94. PMID 11526483 DOI: 10.1038/sj.onc.1204459  1
2001 Eiges R, Schuldiner M, Drukker M, Yanuka O, Itskovitz-Eldor J, Benvenisty N. Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Current Biology : Cb. 11: 514-8. PMID 11413002 DOI: 10.1016/S0960-9822(01)00144-0  1
2001 Eden A, Van Nedervelde L, Drukker M, Benvenisty N, Debourg A. Involvement of branched-chain amino acid aminotransferases in the production of fusel alcohols during fermentation in yeast. Applied Microbiology and Biotechnology. 55: 296-300. PMID 11341309 DOI: 10.1007/s002530000506  1
2000 Schuldiner M, Yanuka O, Itskovitz-Eldor J, Melton DA, Benvenisty N. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 97: 11307-12. PMID 11027332 DOI: 10.1073/pnas.97.21.11307  1
2000 Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M, Soreq H, Benvenisty N. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Molecular Medicine (Cambridge, Mass.). 6: 88-95. PMID 10859025  1
2000 Ben-Yosef T, Benvenisty N. Hereditary cancer and developmental abnormalities. Biology of the Neonate. 77: 1-11. PMID 10658824  1
1999 Eden A, Benvenisty N. Involvement of branched-chain amino acid aminotransferase (Bcat1/Eca39) in apoptosis. Febs Letters. 457: 255-61. PMID 10471790 DOI: 10.1016/S0014-5793(99)01054-6  1
1999 Ben-Porath I, Yanuka O, Benvenisty N. The tmp gene, encoding a membrane protein, is a c-Myc target with a tumorigenic activity. Molecular and Cellular Biology. 19: 3529-39. PMID 10207076  1
1998 Ben-Yosef T, Yanuka O, Halle D, Benvenisty N. Involvement of Myc targets in c-myc and N-myc induced human tumors. Oncogene. 17: 165-71. PMID 9674700 DOI: 10.1038/sj.onc.1201939  1
1998 Ben-Yosef T, Eden A, Benvenisty N. Characterization of murine BCAT genes: Bcat1, a c-Myc target, and its homolog, Bcat2. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 9: 595-7. PMID 9657861 DOI: 10.1007/s003359900825  1
1998 Ben-Porath I, Kozak CA, Benvenisty N. Chromosomal mapping of Tmp (Emp1), Xmp (Emp2), and Ymp (Emp3), genes encoding membrane proteins related to Pmp22. Genomics. 49: 443-7. PMID 9615230 DOI: 10.1006/geno.1998.5238  1
1998 Eden A, Benvenisty N. Characterization of a branched-chain amino-acid aminotransferase from Schizosaccharomyces pombe Yeast. 14: 189-194. PMID 9483807 DOI: 10.1002/(SICI)1097-0061(19980130)14:2<189::AID-YEA210>3.0.CO;2-V  1
1998 Schuldiner O, Yanover C, Benvenisty N. Computer analysis of the entire budding yeast genome for putative targets of the GCN4 transcription factor. Current Genetics. 33: 16-20. PMID 9472075 DOI: 10.1007/s002940050303  1
1997 Levinson-Dushnik M, Benvenisty N. Involvement of hepatocyte nuclear factor 3 in endoderm differentiation of embryonic stem cells Molecular and Cellular Biology. 17: 3817-3822. PMID 9199315  1
1997 Ben-Yosef T, Eden A, Yanuka O, Benvenisty N. Characterization of ec439, a genetic target for c-myc regulation, in yeast, mice and man Faseb Journal. 11: A1250.  1
1996 Cohen H, Trus M, Benvenisty N, Reshef L. Identification of differentially expressed genes during hepatocytes development and characterization of their prenatal hormonal induction European Journal of Biochemistry. 242: 550-556. PMID 9022681  1
1996 Ben-Porath I, Benvenisty N. Characterization of a tumor-associated gene, a member of a novel family of genes encoding membrane glycoproteins Gene. 183: 69-75. PMID 8996089 DOI: 10.1016/S0378-1119(96)00475-1  1
1996 Ben-Yosef T, Yanuka O, Benvenisty N. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast Oncogene. 13: 1859-1866. PMID 8934531  1
1996 Eden A, Simchen G, Benvenisty N. Two yeast homologs of ECA39, a target for c-Myc regulation, code for cytosolic and mitochondrial branched-chain amino acid aminotransferases Journal of Biological Chemistry. 271: 20242-20245. PMID 8702755 DOI: 10.1074/jbc.271.34.20242  1
1996 Schuldiner O, Eden A, Ben-Yosef T, Yanuka O, Simchen G, Benvenisty N. ECA39, a conserved gene regulated by c-Myc in mice, is involved in G1/S cell cycle regulation in yeast. Proceedings of the National Academy of Sciences of the United States of America. 93: 7143-8. PMID 8692959 DOI: 10.1073/pnas.93.14.7143  1
1995 Benvenisty N, Ornitz DM. BK1: An FGF-responsive central nervous system-derived cell line Growth Factors. 12: 49-55. PMID 8527163 DOI: 10.3109/08977199509003213  1
1995 Dushnik-Levinson M, Benvenisty N. Embryogenesis in vitro: Study of differentiation of embryonic stem cells Neonatology. 67: 77-83. PMID 7766734 DOI: 10.1159/000244147  1
1994 Yanuka-Kashles O, Cohen H, Trus M, Aran A, Benvenisty N, Reshef L. Transcriptional regulation of the phosphoenolpyruvate carboxykinase gene by cooperation between hepatic nuclear factors Molecular and Cellular Biology. 14: 7124-7133. PMID 7935427  1
1992 Benvenisty N, Ornitz DM, Bennett GL, Sahagan BG, Kuo A, Cardiff RD, Leder P. Brain tumours and lymphomas in transgenic mice that carry HTLV-I LTR/c-myc and Ig/tax genes. Oncogene. 7: 2399-405. PMID 1461648  1
1992 Benvenisty N, Leder A, Kuo A, Leder P. An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes & Development. 6: 2513-23. PMID 1340466  1
1991 Shoshani T, Benvenisty N, Trus M, Reshef L. Cis -regulatory elements that confer differential expression upon the rat gene encoding phosphoenolpyruvate carboxykinase in kidney and liver Gene. 101: 279-283. PMID 2055492 DOI: 10.1016/0378-1119(91)90424-A  1
1990 Trus M, Benvenisty N, Cohen H, Reshef L. Developmentally regulated interactions of liver nuclear factors with the rat phosphoenolpyruvate carboxykinase promoter Molecular and Cellular Biology. 10: 2418-2422. PMID 2325658  1
1990 Brandes R, Arad R, Benvenisty N, Weil S, Bar-Tana J. The induction of adipose conversion by bezafibrate in 3T3-L1 cells. Synergism with dibutyryl-cAMP Bba - Molecular Cell Research. 1054: 219-224. PMID 1976021 DOI: 10.1016/0167-4889(90)90244-8  1
1989 Benvenisty N, Nechushtan H, Cohen H, Reshef L. Separate cis-regulatory elements confer expression of phosphoenolpyruvate carboxykinase (GTP) gene in different cell lines Proceedings of the National Academy of Sciences of the United States of America. 86: 1118-1122. PMID 2919162  1
1989 Benvenisty N, Shoshani T, Farkash Y, Soreq H, Reshef L. trans activation of rat phosphoenolpyruvate carboxykinase (GTP) gene expression by micro-coinjection of rat liver mRNA in Xenopus laevis oocytes. Molecular and Cellular Biology. 9: 5244-7. PMID 2601721  1
1989 Benvenisty N. A molecular view of tissue differentiation and development Journal of the Royal College of Physicians of London. 23: 156-160. PMID 2475624  1
1987 Nechushtan H, Benvenisty N, Brandeis R, Reshef L. Glucocorticoids control phosphoenolpyruvate carboxykinase gene expression in a tissue specific manner Nucleic Acids Research. 15: 6405-6417. PMID 3627993  1
1987 Benvenisty N, Reshef L. Developmental expression and modification of genes Neonatology. 52: 61-69. PMID 3307929 DOI: 10.1159/000242685  1
1987 Cohen H, Benvenisty N, Reshef L. Fate of polyoma origin of replication after its direct introduction into mice Febs Letters. 223: 347-351. PMID 2822492 DOI: 10.1016/0014-5793(87)80317-4  1
1986 Benvenisty N, Reshef L. Direct introduction of genes into rats and expression of the genes Proceedings of the National Academy of Sciences of the United States of America. 83: 9551-9555. PMID 3540943  1
1985 Cohen H, Gidoni B, Shouval D, Benvenisty N, Mencher D, Meyuhas O, Reshef L. Conservation from rat to human of cytosolic phosphoenolpyruvate carboxykinase and the control of its gene expression Febs Letters. 180: 175-180. PMID 2981716 DOI: 10.1016/0014-5793(85)81066-8  1
1985 Benvenisty N, Mencher D, Meyuhas O, Razin A, Reshef L. Sequential changes in DNA methylation patterns of the rat phosphoenolpyruvate carboxykinase gene during development Proceedings of the National Academy of Sciences of the United States of America. 82: 267-271. PMID 2578665 DOI: 10.1073/pnas.82.2.267  1
1985 Benvenisty N, Szyf M, Mencher D, Razin A, Reshef L. Tissue-specific hypomethylation and expression of rat phosphoenolpyruvate carboxykinase gene induced by in vivo treatment of fetuses and neonates with 5-azacytidine Biochemistry. 24: 5015-5019. PMID 2416339  1
1985 Benvenisty N, Razin A, Reshef L. Developmental changes in the methylation pattern, chromatin conformation and expression of the rat phosphoenolpyruvate carboxykinase gene Progress in Clinical and Biological Research. 198: 185-199. PMID 2415990  1
1984 Mencher D, Cohen H, Benvenisty N, Meyuhas O, Reshef L. Primary activation of cytosolic phosphoenolpyruvate carboxykinase gene in fetal rat liver and the biogenesis of its mRNA European Journal of Biochemistry. 141: 199-203. PMID 6723657  1
1983 Benvenisty N, Simchon EB, Cohen H, Mencher D, Meyuhas O, Reshef L. Control of the activity of phosphoenolpyruvate carboxykinase and the level of its mRNA in livers of newborn rats. Effect of diabetes, glucose load and glucocorticoids European Journal of Biochemistry. 132: 663-668. PMID 6343080 DOI: 10.1111/j.1432-1033.1983.tb07416.x  1
Show low-probability matches.